Pfizer settles U.S. marketing case for Rapamune
Wednesday, July 31, 2013 - 10:00
in Mathematics & Economics
Pfizer Inc will pay $490.9 million US to resolve accusations of illegal marketing of the drug Rapamune dating to Pfizer's 2009 acquisition of Wyeth Pharmaceuticals Inc, the U.S. Justice Department says.